Abiomed (ABMD) – Reuters
-
J&J to buy heart pump maker Abiomed for $16.6 billion ahead of consumer health spinoff
-
Big Tech drives S&P 500 to record high in coronavirus rally
-
Abiomed heart pump gets second FDA emergency use nod for COVID-19 patients
-
Graphic: For veteran Netflix shareholders, it's been a very good decade
-
Some fund managers are avoiding Amazon as it leads U.S. market
Back to ABMD Stock Lookup